| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/19/2002 | WO2001017076A9 Tunable laser source with integrated optical amplifier |
| 09/19/2002 | WO2001007483A9 Prognosis and therapy of malignant diseases by antibodies which bind phosphorylated met protein |
| 09/19/2002 | WO1997046589A3 Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods |
| 09/19/2002 | US20020133846 Method for protecting plants |
| 09/19/2002 | US20020133836 Methods to identify swine genetically resistant to F18 E. coli associated diseases |
| 09/19/2002 | US20020133495 Database system and method |
| 09/19/2002 | US20020133306 System and method for calibration and verification of a sample analysis instrument |
| 09/19/2002 | US20020133296 Classification of polypeptides by ligand geometry and related methods |
| 09/19/2002 | US20020133064 Blood sugar lever measuring device and semiconductor integrated circuit |
| 09/19/2002 | US20020133063 Use of targeted glycemic profiles in the calibration of a noninvasive blood glucose monitor |
| 09/19/2002 | US20020133019 Thioflavin derivatives for use in antemortem diagnosis of alzheimer's disease and vivo imaging and prevention of amyloid deposition |
| 09/19/2002 | US20020132992 Reagent system and method for increasing the luminescence of lanthanide(III) macrocyclic complexes |
| 09/19/2002 | US20020132989 Kit for determining DNA double-stranded breaks with anti-gamma-H2A antibodies |
| 09/19/2002 | US20020132988 Generation preferential antibody; construct peptide library, immunize cells, isolating and purify antisera from cells |
| 09/19/2002 | US20020132981 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/19/2002 | US20020132823 Assay method |
| 09/19/2002 | US20020132814 AcrAB-like efflux pumps control resistance to drugs, even in highly resistant microbes; combination of an inhibitor of an AcrAB-like efflux pump and an antibiotic |
| 09/19/2002 | US20020132778 Modulating angiogenesis |
| 09/19/2002 | US20020132770 Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease |
| 09/19/2002 | US20020132758 Method for identifying compounds to treat medical pathologies associated with molecular crystallization |
| 09/19/2002 | US20020132753 Nucleic acids, proteins, and antibodies |
| 09/19/2002 | US20020132500 Electrical connection structure, production method thereof, and electric wiring method |
| 09/19/2002 | US20020132373 Immunoglobulin control region |
| 09/19/2002 | US20020132372 Apparatus for use in the evaluation and detection of magnet labels in sample |
| 09/19/2002 | US20020132371 Amplification of analyte detection by substrates having particle structures with receptors |
| 09/19/2002 | US20020132370 Detection of a blood coagulation activity marker in a body fluid sample |
| 09/19/2002 | US20020132368 Using patterned soild suport for detection of preferential particles in sample; obtain sample, expose to solid support, detect spotting on solid support |
| 09/19/2002 | US20020132367 Device and method for separating components of a fluid sample |
| 09/19/2002 | US20020132365 1,2-dioxetane derivative for use as a substrate in diagnostic immunoassays |
| 09/19/2002 | US20020132363 Method and apparatus for using infrared readings to detect misidentification of a diagnostic test strip in a reflectance spectrometer |
| 09/19/2002 | US20020132361 Selective chemical sensors based on interlinked nanoparticle assemblies |
| 09/19/2002 | US20020132358 For detecting and indicating the caffeine concentration of a beverage |
| 09/19/2002 | US20020132357 Sequence determination of preferential protein; obtain protein, incubate with label, monitor signal form label using mass spectroscopy |
| 09/19/2002 | US20020132351 Monitoring concentration of prefrential chemical intermediates in soil; obtain sample, insert into monitoring apparatus, determine the concentration of dithionites in soil sample |
| 09/19/2002 | US20020132347 Genetically engineered cell for use in the diagnosis, prevntion and treatment of viral diseases |
| 09/19/2002 | US20020132342 Generating immortalized dendritic cells; obtain cells, culture, maintain culture of dendritic cells, monitor gene expression from cell culture |
| 09/19/2002 | US20020132340 Cell culture for use in the diagnosis and treatment of cancer |
| 09/19/2002 | US20020132338 Detection and characterization of microorganisms |
| 09/19/2002 | US20020132322 For use in therapy |
| 09/19/2002 | US20020132319 Peptide mutant of human ERAB or HADH2, its X-ray crystal structure, and materials and method for identification of inhibitors thereof |
| 09/19/2002 | US20020132298 Nucleotide sequences coding polypeptide for use in the treatment of muscular and nervous sytem disosrders |
| 09/19/2002 | US20020132297 Nucleotide sequences coding protein for use in the treatment nflammatory bowel disease, sepsis, viral diseases and rheumatoid arthritis |
| 09/19/2002 | US20020132296 Human Ste20-like stress activated serine/threonine kinase |
| 09/19/2002 | US20020132292 Peptide for use in treatment of gastrointestinal, muscle and respiratory disorders |
| 09/19/2002 | US20020132289 Olfactory receptors and their utilizations |
| 09/19/2002 | US20020132284 Methods of completing a cell culture medium with a lipophilic substance promoting the growth of cells by weight or promoting the biosynthesis of desired substances within the cells |
| 09/19/2002 | US20020132282 Composition for use in the detection of preferential particles in fluids |
| 09/19/2002 | US20020132281 Enzymatic polypeptide for use in the treatment of alzheimer's disease |
| 09/19/2002 | US20020132280 Method for assaying non-spermine/spermidine activity of spermidine/spermine N1-acetyltransferase (SSAT) |
| 09/19/2002 | US20020132278 Measuring level of pregnancy- associated plasma protein-A (PAPP-A) in biological sample from a non-pregnant patient; comparing level with that of control subjects; diagnosing inflammatory condition based on level of PAPP-Acontrol |
| 09/19/2002 | US20020132277 Methods for the rapid detection of actively respiring microorganism |
| 09/19/2002 | US20020132276 Detecting platelet activating protein; obtain platelet sample, incubate with modulator and label, detect signal from complex |
| 09/19/2002 | US20020132275 Methods for detecting the efficacy of anticancer treatments |
| 09/19/2002 | US20020132274 Diagnostic and monitorings methods for cancer |
| 09/19/2002 | US20020132273 Receptor fingerprinting, sensory perception, and biosensors of chemical sensants |
| 09/19/2002 | US20020132272 Non-specific binding resistant protein arrays and methods for making the same |
| 09/19/2002 | US20020132271 Reagents, method and kit for detecting phosphinothricin-N-acetyltransferase protein |
| 09/19/2002 | US20020132270 Kit for use in the detection of parasite in feces |
| 09/19/2002 | US20020132266 Detecting active zone in protein; obtain target protein, incubate with binding particle, expose to laser, detect preferential positional binding of complex, bound complex indicates active zone |
| 09/19/2002 | US20020132264 Solid support for evaluating preferential biopolymers in sample |
| 09/19/2002 | US20020132262 Nucleotide sequences coding tumor suppressor protein for use in the diagnosis and treatment of cancer |
| 09/19/2002 | US20020132260 Quantitative immunohistochemistry (QIHC) |
| 09/19/2002 | US20020132259 Detecting mutation in nucleotide sequences; obtain sample, incubate with probes, expose to preferential protein, detect bound protein |
| 09/19/2002 | US20020132256 Diagnostic tools for analyzing ligand binding; obtain sample, incubate with reaction mixture, detect signal from bound lgand |
| 09/19/2002 | US20020132255 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of breast cancer |
| 09/19/2002 | US20020132254 Molecular labeling and assay systems using poly (amino acid)-metal ion complexes as linkers |
| 09/19/2002 | US20020132253 Nucleotide sequences coding membrane protein for use in diagnosis and treatment of athersclerosis, infections, arthritis, cancer, kidney and nervous system disorders |
| 09/19/2002 | US20020132252 Nucleotide sequences coding membrane protein for use in the diagnosis and treatment of infections, arthritis, nervous system and kidney disorders, cancer and atherosclerosis |
| 09/19/2002 | US20020132248 Generating nonradioactive marker for use in genetic analysis; obtain adjusted adaptor nucleotide sequences, incubate with target sequences, translated and recover protein |
| 09/19/2002 | US20020132247 Screening for modulator of tumor activity; obtain cell, expression vectors or animal model which codes prefrential kinase, incubate with antiproliferative agent, monitor adjustment in enzyme activity |
| 09/19/2002 | US20020132246 Cellular arrays and methods of detecting and using genetic disorder markers |
| 09/19/2002 | US20020132242 Nucleic acid archiving |
| 09/19/2002 | US20020132241 Detecting preferential particles in sample; obtain sample, incubate with primers, amplify, detect amplicons, presence of amplicons indicates the presence of target particle |
| 09/19/2002 | US20020132240 Nucleotide sequences coding membrane proteins for use in treatment of cancer, infections, cardiavascular, nervous system, skin and kidney disorders |
| 09/19/2002 | US20020132239 Cell lineage markers |
| 09/19/2002 | US20020132237 Detecting ovarian cancer humans; obtain sample, incubate with preferential oligonucleotides, monitor hybridization, compare to control, evaluate for cancer |
| 09/19/2002 | US20020132236 Specific inhibitors of ribosome recycling factors (RRF) |
| 09/19/2002 | US20020132235 Measurement of protective genes in allograft rejection |
| 09/19/2002 | US20020132233 Diagnostic reagent for use in the detection of cancer |
| 09/19/2002 | US20020132232 Test piece, method of and apparatus for manufacturing the test piece and method of and system for reading the same |
| 09/19/2002 | US20020132231 Methods for simultaneously detecting both members of a binding pair |
| 09/19/2002 | US20020132230 Detecting concentration of microorganism in sample; obtain sample, concentrate microorganisms, remove fluid from above, replace with less dense fluid, withdraw fluid containing microorganism, detect signal form microorganisms |
| 09/19/2002 | US20020132229 Detecting modulators of viral propagation; obtain cell, transform with expression vector containing modulator, incubate cell with virus, recover propagating cells |
| 09/19/2002 | US20020132225 Compositions and methods for prolonging survival of chilled platelets |
| 09/19/2002 | US20020132223 Methods for modulating activity of the FXR nuclear receptor |
| 09/19/2002 | US20020132221 Solid support for use in detection of presence and/or concentration of specific particles in fluids and gases |
| 09/19/2002 | US20020132021 Elicited plant products |
| 09/19/2002 | US20020131976 Tuberculosis vaccine |
| 09/19/2002 | US20020131972 Multi-partite ligands and methods of identifying and using same |
| 09/19/2002 | US20020131966 Anti-idiotypic antibodies of vascular endothelial growth factor and use thereof as drugs |
| 09/19/2002 | US20020131963 Methods and compositions for treating type i diabetes using glutamic acid decarboxylase |
| 09/19/2002 | US20020131960 Eukaryotic cell expressing beta 2-microglobulin and at least one exogenous accessory molecule; used to stimulate T cells of any patient of a given human leukocyte antigen (HLA) type |
| 09/19/2002 | US20020131958 Method for purifying a biological composition |
| 09/19/2002 | US20020131951 Biodegradable poly(beta-amino esters) and uses thereof |
| 09/19/2002 | US20020131904 For collecting and transporting fluid samples whereby the device and fluid sample are subjected to centrifugation to cause separation of the heavier fraction from lighter fraction of fluid sample |
| 09/19/2002 | US20020131900 Sensor comprising a hydrophilic matrix material |
| 09/19/2002 | US20020131899 Biologic electrode array with integrated optical detector |
| 09/19/2002 | US20020131898 To determine the concentration of alcohol in various gas mixtures; efficiency |
| 09/19/2002 | US20020131897 For determining the concentration of one or more plasma proteins in a sample by immunoturbidimetry in a blood analyzer |
| 09/19/2002 | US20020131893 For domestic use for the self- detection of food allergies by determining the presence of antibodies against specific antigens in a stool sample |